| Product NDC: | 61314-019 |
| Proprietary Name: | DORZOLAMIDE HYDROCHLORIDE |
| Non Proprietary Name: | dorzolamide hydrochloride |
| Active Ingredient(s): | 20 mg/mL & nbsp; dorzolamide hydrochloride |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 61314-019 |
| Labeler Name: | Sandoz Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078981 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090601 |
| Package NDC: | 61314-019-10 |
| Package Description: | 10 mL in 1 BOTTLE (61314-019-10) |
| NDC Code | 61314-019-10 |
| Proprietary Name | DORZOLAMIDE HYDROCHLORIDE |
| Package Description | 10 mL in 1 BOTTLE (61314-019-10) |
| Product NDC | 61314-019 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dorzolamide hydrochloride |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20090601 |
| Marketing Category Name | ANDA |
| Labeler Name | Sandoz Inc. |
| Substance Name | DORZOLAMIDE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |